Taiwan
· Delayed Price · Currency is TWD Bioteque Statistics
Total Valuation
Bioteque has a market cap or net worth of TWD 7.97 billion. The enterprise value is 6.92 billion.
| Market Cap | 7.97B |
| Enterprise Value | 6.92B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Jul 28, 2025 |
Share Statistics
Bioteque has 69.30 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 69.30M |
| Shares Outstanding | 69.30M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.40% |
| Owned by Insiders (%) | 3.84% |
| Owned by Institutions (%) | 9.00% |
| Float | 58.26M |
Valuation Ratios
The trailing PE ratio is 14.92.
| PE Ratio | 14.92 |
| Forward PE | n/a |
| PS Ratio | 3.80 |
| PB Ratio | 2.46 |
| P/TBV Ratio | 2.46 |
| P/FCF Ratio | 12.47 |
| P/OCF Ratio | 10.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.36, with an EV/FCF ratio of 10.83.
| EV / Earnings | 12.88 |
| EV / Sales | 3.30 |
| EV / EBITDA | 8.36 |
| EV / EBIT | 10.45 |
| EV / FCF | 10.83 |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.51 |
| Quick Ratio | 2.15 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 1.10 |
| Interest Coverage | 75.20 |
Financial Efficiency
Return on equity (ROE) is 17.15% and return on invested capital (ROIC) is 10.55%.
| Return on Equity (ROE) | 17.15% |
| Return on Assets (ROA) | 8.68% |
| Return on Invested Capital (ROIC) | 10.55% |
| Return on Capital Employed (ROCE) | 17.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.44 |
| Inventory Turnover | 3.92 |
Taxes
In the past 12 months, Bioteque has paid 152.54 million in taxes.
| Income Tax | 152.54M |
| Effective Tax Rate | 22.12% |
Stock Price Statistics
The stock price has decreased by -9.43% in the last 52 weeks. The beta is 0.10, so Bioteque's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -9.43% |
| 50-Day Moving Average | 120.78 |
| 200-Day Moving Average | 124.21 |
| Relative Strength Index (RSI) | 53.64 |
| Average Volume (20 Days) | 98,815 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioteque had revenue of TWD 2.09 billion and earned 537.11 million in profits. Earnings per share was 7.71.
| Revenue | 2.09B |
| Gross Profit | 924.57M |
| Operating Income | 661.79M |
| Pretax Income | 689.65M |
| Net Income | 537.11M |
| EBITDA | 813.48M |
| EBIT | 661.79M |
| Earnings Per Share (EPS) | 7.71 |
Balance Sheet
The company has 1.75 billion in cash and 700.00 million in debt, giving a net cash position of 1.05 billion or 15.18 per share.
| Cash & Cash Equivalents | 1.75B |
| Total Debt | 700.00M |
| Net Cash | 1.05B |
| Net Cash Per Share | 15.18 |
| Equity (Book Value) | 3.24B |
| Book Value Per Share | 46.71 |
| Working Capital | 1.42B |
Cash Flow
In the last 12 months, operating cash flow was 740.45 million and capital expenditures -101.58 million, giving a free cash flow of 638.88 million.
| Operating Cash Flow | 740.45M |
| Capital Expenditures | -101.58M |
| Free Cash Flow | 638.88M |
| FCF Per Share | 9.22 |
Margins
Gross margin is 44.13%, with operating and profit margins of 31.59% and 25.64%.
| Gross Margin | 44.13% |
| Operating Margin | 31.59% |
| Pretax Margin | 32.92% |
| Profit Margin | 25.64% |
| EBITDA Margin | 38.83% |
| EBIT Margin | 31.59% |
| FCF Margin | 30.50% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 4.31%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 4.31% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 58.06% |
| Buyback Yield | -0.02% |
| Shareholder Yield | 4.27% |
| Earnings Yield | 6.74% |
| FCF Yield | 8.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 20, 2015. It was a reverse split with a ratio of 0.8006917977.
| Last Split Date | Aug 20, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.8006917977 |
Scores
Bioteque has an Altman Z-Score of 5.35 and a Piotroski F-Score of 8.
| Altman Z-Score | 5.35 |
| Piotroski F-Score | 8 |